ZEPP PE Ratio & Valuation, Is ZEPP Overvalued

Historical Valuation

Zepp Health Corp (ZEPP) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -37.57. The fair price of Zepp Health Corp (ZEPP) is between +Inf to +Inf according to relative valuation method. Compared to the current price of 11.71 USD , Zepp Health Corp By Undervalued By Fair.

Relative Value

Fair Zone

+Inf-+Inf

Current Price：11.71

Fair

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Zepp Health Corp (ZEPP) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Zepp Health Corp (ZEPP) has a current Price-to-Book (P/B) ratio of 0.11. Compared to its 3-year average P/B ratio of 0.55, the current P/B ratio is approximately -79.29% higher. Relative to its 5-year average P/B ratio of 0.62, the current P/B ratio is about -81.52% higher. Zepp Health Corp (ZEPP) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 4.31%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -4.03%, the current FCF yield is about -100.00% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ZEPP competitors is 1.34, providing a benchmark for relative valuation. Zepp Health Corp Corp (ZEPP.N) exhibits a P/S ratio of --, which is -100% above the industry average. Given its robust revenue growth of 43.03%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ZEPP increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ZEPP in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ZEPP currently overvalued or undervalued?

What is Zepp Health Corp (ZEPP) fair value?

ZEPP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Zepp Health Corp (ZEPP) is between +Inf to +Inf according to relative valuation method.

How does ZEPP's valuation metrics compare to the industry average?

The average P/S ratio for ZEPP's competitors is 1.34, providing a benchmark for relative valuation. Zepp Health Corp Corp (ZEPP) exhibits a P/S ratio of --, which is -100.00% above the industry average. Given its robust revenue growth of 43.03%, this premium appears sustainable.

What is the current P/B ratio for Zepp Health Corp (ZEPP) as of Apr 02 2026?

As of Apr 02 2026, Zepp Health Corp (ZEPP) has a P/B ratio of 0.11. This indicates that the market values ZEPP at 0.11 times its book value.

What is the current FCF Yield for Zepp Health Corp (ZEPP) as of Apr 02 2026?

As of Apr 02 2026, Zepp Health Corp (ZEPP) has a FCF Yield of 0.00%. This means that for every dollar of Zepp Health Corp's market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Zepp Health Corp (ZEPP) as of Apr 02 2026?

As of Apr 02 2026, Zepp Health Corp (ZEPP) has a Forward P/E ratio of 3.07. This means the market is willing to pay $3.07 for every dollar of Zepp Health Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Zepp Health Corp (ZEPP) as of Apr 02 2026?

As of Apr 02 2026, Zepp Health Corp (ZEPP) has a Forward P/S ratio of 0.00. This means the market is valuing ZEPP at $0.00 for every dollar of expected revenue over the next 12 months.

ZEPP Valuation